16
ICD10 code of Uterine Carcinosarcoma (MMMT) and ICD9 code
What is the ICD10 code for Uterine Carcinosarcoma (MMMT)? And the ICD9 code for Uterine Carcinosarcoma (MMMT)?
ICD-10 code for Uterine Carcinosarcoma (MMMT): C57.9
ICD-9 code for Uterine Carcinosarcoma (MMMT): 182.0
Uterine carcinosarcoma, also known as malignant mixed Müllerian tumor (MMMT), is a rare and aggressive form of cancer that affects the uterus. This cancer is characterized by the presence of both malignant epithelial and mesenchymal components. Assigning appropriate diagnostic codes is crucial for accurate medical record keeping and billing purposes.
In the International Classification of Diseases, Tenth Revision (ICD-10), the specific code for uterine carcinosarcoma is C57.9. This code falls under the category of malignant neoplasms of the female genital organs. The "C" indicates a malignant neoplasm, and the digits "57" specify the uterus. The suffix ".9" denotes an unspecified site within the uterus.
In the previous version, the ICD-9 code for uterine carcinosarcoma was 182.0. This code was used to identify malignant neoplasms of the body of the uterus. However, it is important to note that as of October 1, 2015, the United States transitioned from ICD-9 to ICD-10 for diagnostic coding.
By utilizing these specific codes, healthcare providers can accurately document and track cases of uterine carcinosarcoma, facilitating research, treatment planning, and statistical analysis.
In the International Classification of Diseases, Tenth Revision (ICD-10), the specific code for uterine carcinosarcoma is C57.9. This code falls under the category of malignant neoplasms of the female genital organs. The "C" indicates a malignant neoplasm, and the digits "57" specify the uterus. The suffix ".9" denotes an unspecified site within the uterus.
In the previous version, the ICD-9 code for uterine carcinosarcoma was 182.0. This code was used to identify malignant neoplasms of the body of the uterus. However, it is important to note that as of October 1, 2015, the United States transitioned from ICD-9 to ICD-10 for diagnostic coding.
By utilizing these specific codes, healthcare providers can accurately document and track cases of uterine carcinosarcoma, facilitating research, treatment planning, and statistical analysis.
Diseasemaps
